Cme shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of Cme (CME) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in Cme
Tip: Access up to 7 years of quarterly data
All positions including Cme held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cme by Capital Research Global Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.8B | 9.0M | 200.22 |
| 2023-06-30 | $1.7B | 9.2M | 185.29 |
| 2023-03-31 | $1.6B | 8.2M | 191.52 |
| 2022-12-31 | $1.0B | 5.9M | 168.16 |
| 2022-03-31 | $1.9B | 7.8M | 237.86 |
| 2021-12-31 | $2.1B | 9.1M | 228.46 |
| 2021-09-30 | $1.6B | 8.5M | 193.38 |
| 2021-06-30 | $2.0B | 9.3M | 212.68 |
| 2021-03-31 | $2.0B | 9.8M | 204.23 |
| 2020-12-31 | $2.0B | 11M | 182.05 |
| 2020-09-30 | $1.9B | 11M | 167.31 |
| 2020-06-30 | $1.8B | 11M | 162.54 |
| 2020-03-31 | $2.2B | 13M | 172.91 |
| 2019-12-31 | $2.7B | 14M | 200.72 |
| 2019-09-30 | $2.8B | 13M | 211.34 |
| 2019-06-30 | $2.7B | 14M | 194.11 |
| 2019-03-31 | $2.0B | 12M | 164.58 |
| 2018-12-31 | $2.1B | 11M | 188.12 |
| 2018-09-30 | $1.9B | 11M | 170.21 |
| 2018-06-30 | $860M | 5.2M | 163.92 |
| 2018-03-31 | $199M | 1.2M | 161.74 |
| 2017-12-31 | $179M | 1.2M | 146.05 |
| 2017-03-31 | $146M | 1.2M | 118.80 |
| 2016-12-31 | $142M | 1.2M | 115.35 |
| 2016-09-30 | $168M | 1.6M | 104.52 |
| 2016-06-30 | $231M | 2.4M | 97.40 |
| 2016-03-31 | $262M | 2.7M | 96.05 |
| 2015-12-31 | $398M | 4.4M | 90.60 |
| 2015-09-30 | $407M | 4.4M | 92.74 |
| 2015-03-31 | $836M | 8.8M | 94.71 |
| 2014-12-31 | $967M | 11M | 85.30 |
| 2014-06-30 | $390M | 5.5M | 70.95 |
| 2013-12-31 | $235M | 3.0M | 78.46 |
| 2013-09-30 | $222M | 3.0M | 73.88 |
| 2013-06-30 | $228M | 3.0M | 75.98 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors